Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

Autor: Maureen Dillon, L. Garrett, Scott Chasan-Taber, R. Zabaneh, Wadi N. Suki, Steven K. Burke, D. Fischer, B. N. Ling, Jon A. Reed, J. L. Cangiano, Andrew T. Blair
Rok vydání: 2007
Předmět:
Zdroj: Kidney International. 72(9):1130-1137
ISSN: 0085-2538
DOI: 10.1038/sj.ki.5002466
Popis: Elevated serum phosphorus and calcium are associated with arterial calcification and mortality in dialysis patients. Unlike calcium-based binders, sevelamer attenuates arterial calcification but it is unknown whether sevelamer affects mortality or morbidity. In a multicenter, randomized, open-label, parallel design trial we compared sevelamer and calcium-based binders on all-cause and cause-specific mortality (cardiovascular, infection, and other) in prevalent hemodialysis patients. A total of 2103 patients were initially randomized to treatment and 1068 patients completed the study. All-cause mortality rates and cause-specific mortality rates were not significantly different. There was a significant age interaction on the treatment effect. Only in patients over 65 years of age was there a significant effect of sevelamer in lowering the mortality rate. There was a suggestion that sevelamer was associated with lower overall, but not cardiovascular-linked, mortality in older patients. We suggest that further research is needed to confirm these findings.
Databáze: OpenAIRE